ENMS With Balance Feedback for Post-stroke Ankle-foot Rehabilitation
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Jun 14, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new robotic device designed to help people who have had a stroke improve their walking ability. The device, called the ENMS with Balance Feedback, is lightweight and wearable. It aims to assist individuals with foot drop (where the foot cannot lift properly) and foot inversion (where the foot turns inward) by providing support and feedback to help them regain better control and coordination of their lower limbs while walking. The researchers believe that using this device could lead to lasting improvements in a person's walking pattern over time.
To participate in this trial, you need to be at least six months post-stroke and have mild to moderate issues with movement in your affected leg. You should be able to stand and walk without help, and have good enough thinking skills to follow simple instructions. However, if you have severe stiffness in your ankle or are currently undergoing other rehabilitation treatments for your legs, you won't be eligible. If you join the trial, you can expect to receive training on how to use the device and participate in sessions aimed at improving your walking. This could be a great opportunity to enhance your mobility and independence after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 6 months after the onset of stroke
- • Have sufficient cognition to follow simple instructions, as well as understand the content and purpose of the experiment (Mini-Mental State Examination (MMSE) score \>21).
- • Have mild-to-moderate motor impairment in the affected lower limb with foot drop but be capable of standing and walking without manual assistance.
- • Fugl-Meyer Assessment (FMA), total score on the lower limb \<20
- • Functional Ambulatory Category (FAC) ≥4
- • Berg Balance Scale (BBS) ≥40
- Exclusion Criteria:
- • The exclusion criteria will be server spasticity at the ankle joint measured by Modified Ashworth Score (MAS) \>3.
- • Receiving other lower limb rehabilitative interventions at the same time
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials